The Alexion Takeover Is a Major Expansion for AstraZeneca. Why the Stock Is Down 7%. – Barron's

1. The Alexion Takeover Is a Major Expansion for AstraZeneca. Why the Stock Is Down 7%.  Barron’s
2. AstraZeneca to buy Alexion Pharmaceuticals in $39 billion deal  CNBC Television
3. AstraZeneca Stock Tumbles On $39 Billion Alexion Pharmaceuticals Takeover  Investor’s Business Daily
4. AstraZeneca’s $39 Billion Deal for Alexion Stacks Up to Scrutiny  Bloomberg
5. Alexion, Huntington, Take-Two – Monday’s Premarket Movers  TheStreet
6. View Full Coverage on Google News

Source: Air Tools